# Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss

> **NCT00180778** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Imperial College London**

## Conditions studied

- Antiphospholipid Syndrome

## Interventions

- **DRUG:** Low dose steroids

## Key facts

- **NCT ID:** NCT00180778
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2005-10
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Literature highlighted unnecessary side effects from the relevant combination.
- **Last updated:** 2024-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00180778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00180778, "Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00180778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*